Aristea Translational Medicine Corporation
  Researching Drugs to Insure Sound Drug Developments
Your Subtitle text
M

Aristea Announces Plans for Phase III Development of AR-YU-69

A Drug for mild Traumatic Brain Injury (Concussion) with Applications in Alzheimer’s Disease Prevention



Sci. Transl. Med. 2, 61rv6 (2010).

Researching Drugs to Insure Sound Drug Developments


To Achieve Regulatory Approval

The Drug Must Possess Efficacy and

The Development Must Allow the Drug to Exhibit This Efficacy.


Website Builder